Evidence-based pharmacotherapy for prevention and management of cardiac allograft vasculopathy

This publication has 86 references indexed in Scilit:

• Pharmacokinetic Comparison of the Potential Over-the-Counter Statins Simvastatin, Lovastatin, Fluvastatin and Pravastatin
  Clinical Pharmacokinetics, 2008
• 398: Premature termination of a prospective, open label, randomized, multicenter study of sirolimus to replace calcineurin inhibitors (CNI) in a standard care regimen of CNI, MMF and corticosteroids early after heart transplantation
  The Journal of Heart and Lung Transplantation, 2007
• Transplant-related Immunosuppression: A Review of Immunosuppression and Pulmonary Infections
  Proceedings of the American Thoracic Society, 2005
• Everolimus for the Prevention of Allograft Rejection and Vasculopathy in Cardiac-Transplant Recipients
  New England Journal of Medicine, 2003
• TOR inhibitors and cardiac allograft vasculopathy: is inhibition of intimal thickening an adequate surrogate of benefit?
  The Journal of Heart and Lung Transplantation, 2003
• Metabolic Abnormalities Characteristic of Dysmetabolic Syndrome Predict the Development of Transplant Coronary Artery Disease
  Circulation, 2001
• Efficacy of augmented immunosuppressive therapy for early vasculopathy in heart transplantation
  JACC, 1998
• Effect of Pravastatin on Outcomes after Cardiac Transplantation
  New England Journal of Medicine, 1995
• A Preliminary Study of Diltiazem in the Prevention of Coronary Artery Disease in Heart-Transplant Recipients
  New England Journal of Medicine, 1993
• Chest Pain in Cardiac-Transplant Recipients
  New England Journal of Medicine, 1991